“Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)”. Clinical Oncohematology. Basic Research and Clinical Practice 16, no. 2 (March 3, 2023): 227–228. Accessed January 13, 2026. https://bloodjournal.ru/index.php/coh/article/view/29.